Basic Information
| RNALocate ID: | RLID:11001430 |
| RNA Symbol: | hsa-miR-182-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-182 |
| RNA ID: | miRBase:MIMAT0000259 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | Jurkat-derived T cell line (J77cl20) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001634 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001635 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001636 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001637 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:01001638 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001426 | Exosome | Pooled sera | 27278097 |
| RLID:11001427 | Exosome | Bronchoalveolar lavage fluid|Pooled sera | 27278097 |
| RLID:11001428 | Exosome | Human milk | 28688106 |
| RLID:11001429 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001431 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001432 | Exosome | Breast milk | 22211110 |
| RLID:11001433 | Exosome | Brain tissue | 23382797 |
| RLID:11001434 | Exosome | Plasma | 23663360 |
| RLID:11001435 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001436 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001437 | Microvesicle | Serum | 24797360 |
| RLID-D:11000052 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000321 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-182-5p | Oral squamous cell carcinoma | MNDR-E-MI-20345 |
| MNDR | hsa-miR-182-5p | Large cell neuroendocrine cancer | MNDR-E-MI-20346 |
| MNDR | hsa-miR-182-5p | Medulloblastoma | MNDR-E-MI-20347 |
| MNDR | hsa-miR-182-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-20348 |
| MNDR | hsa-miR-182-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-20349 |
| MNDR | hsa-miR-182-5p | Ovarian clear cell carcinoma | MNDR-E-MI-20350 |
| MNDR | hsa-miR-182-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-20351 |
| MNDR | hsa-miR-182-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20352 |
| MNDR | hsa-miR-182-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-20353 |
| MNDR | hsa-miR-182-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20354 |
| MNDR | hsa-miR-182-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-20355 |
| MNDR | hsa-miR-182-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20356 |
| MNDR | hsa-miR-182-5p | Triple negative breast cancer | MNDR-E-MI-20357 |
| MNDR | hsa-miR-182-5p | Breast cancer luminal | MNDR-E-MI-20358 |
| MNDR | hsa-miR-182-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-20359 |
| MNDR | hsa-miR-182-5p | Hearing loss central | MNDR-E-MI-20360 |
| MNDR | hsa-miR-182-5p | Sensorineural hearing loss | MNDR-E-MI-20361 |
| MNDR | hsa-miR-182-5p | Small intestine cancer | MNDR-E-MI-20362 |
| MNDR | hsa-miR-182-5p | Prostate cancer | MNDR-E-MI-20363 |
| MNDR | hsa-miR-182-5p | Gastric cancer | MNDR-E-MI-20364 |
| MNDR | hsa-miR-182-5p | Gastric lymphoma | MNDR-E-MI-20365 |
| MNDR | hsa-miR-182-5p | Alzheimer disease | MNDR-E-MI-20366 |
| MNDR | hsa-miR-182-5p | Bladder cancer | MNDR-E-MI-20367 |
| MNDR | hsa-miR-182-5p | Head and neck cancer | MNDR-E-MI-20368 |
| MNDR | hsa-miR-182-5p | Ataxia telangiectasia | MNDR-E-MI-20369 |
| MNDR | hsa-miR-182-5p | Cardiovascular disease | MNDR-E-MI-20370 |
| MNDR | hsa-miR-182-5p | Lung cancer | MNDR-E-MI-20371 |
| MNDR | hsa-miR-182-5p | Down syndrome | MNDR-E-MI-20372 |
| MNDR | hsa-miR-182-5p | Parkinson disease | MNDR-E-MI-20373 |
| MNDR | hsa-miR-182-5p | Basal-like breast cancer | MNDR-E-MI-20374 |
| MNDR | hsa-miR-182-5p | Neuroendocrine neoplasia | MNDR-E-MI-20375 |
| MNDR | hsa-miR-182-5p | Thyroid cancer | MNDR-E-MI-20376 |
| MNDR | hsa-miR-182-5p | Pituitary neoplasms | MNDR-E-MI-20377 |
| MNDR | hsa-miR-182-5p | Pancreatic cancer | MNDR-E-MI-20378 |
| MNDR | hsa-miR-182-5p | Melanoma | MNDR-E-MI-20379 |
| MNDR | hsa-miR-182-5p | Rectum adenocarcinoma | MNDR-E-MI-20380 |
| MNDR | hsa-miR-182-5p | Nephroblastoma | MNDR-E-MI-20381 |
| MNDR | hsa-miR-182-5p | Colon cancer | MNDR-E-MI-20382 |
| MNDR | hsa-miR-182-5p | Colon adenocarcinoma | MNDR-E-MI-20383 |
| MNDR | hsa-miR-182-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-20384 |
| MNDR | hsa-miR-182-5p | Familial ovarian cancer | MNDR-E-MI-20385 |
| MNDR | hsa-miR-182-5p | Hereditary spastic paraplegia | MNDR-E-MI-20386 |
| MNDR | hsa-miR-182-5p | Prostate adenocarcinoma | MNDR-E-MI-20387 |
| MNDR | hsa-miR-182-5p | Kidney cancer | MNDR-E-MI-20388 |
| MNDR | hsa-miR-182-5p | Adenocarcinoma | MNDR-E-MI-20389 |
| MNDR | hsa-miR-182-5p | Carcinoma ductal breast | MNDR-E-MI-20390 |
| MNDR | hsa-miR-182-5p | Invasive ductal carcinoma | MNDR-E-MI-20391 |
| MNDR | hsa-miR-182-5p | Glioblastoma | MNDR-E-MI-20392 |
| MNDR | hsa-miR-182-5p | Astrocytoma | MNDR-E-MI-20393 |
| MNDR | hsa-miR-182-5p | Glioma | MNDR-E-MI-20394 |
| MNDR | hsa-miR-182-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-20395 |
| MNDR | hsa-miR-182-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-20396 |
| MNDR | hsa-miR-182-5p | Epilepsy temporal lobe | MNDR-E-MI-20397 |
| MNDR | hsa-miR-182-5p | Osteosarcoma | MNDR-E-MI-20398 |
| MNDR | hsa-miR-182-5p | Liposarcoma | MNDR-E-MI-20399 |
| MNDR | hsa-miR-182-5p | Breast carcinoma | MNDR-E-MI-20400 |
| MNDR | hsa-miR-182-5p | Uterine cancer | MNDR-E-MI-20401 |
| MNDR | hsa-miR-182-5p | Gastric adenocarcinoma | MNDR-E-MI-20402 |
| MNDR | hsa-miR-182-5p | Cervical squamous cell carcinoma | MNDR-E-MI-20403 |
| MNDR | hsa-miR-182-5p | Pituitary adenoma | MNDR-E-MI-20404 |
| MNDR | hsa-miR-182-5p | Lung squamous cell carcinoma | MNDR-E-MI-20405 |
| MNDR | hsa-miR-182-5p | Lung adenocarcinoma | MNDR-E-MI-20406 |
| MNDR | hsa-miR-182-5p | Thyroid carcinoma | MNDR-E-MI-20407 |
| MNDR | hsa-miR-182-5p | Ovarian carcinoma | MNDR-E-MI-20408 |
| MNDR | hsa-miR-182-5p | Bladder urothelial carcinoma | MNDR-E-MI-20409 |
| MNDR | hsa-miR-182-5p | Pancreatic adenocarcinoma | MNDR-E-MI-20410 |
| MNDR | hsa-miR-182-5p | Carcinoma renal cell | MNDR-E-MI-20411 |
| MNDR | hsa-miR-182-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-20412 |
| MNDR | hsa-miR-182-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-20413 |
| MNDR | hsa-miR-182-5p | Large cell carcinoma | MNDR-E-MI-20414 |
| MNDR | hsa-miR-182-5p | Cholangiocarcinoma | MNDR-E-MI-20415 |
| MNDR | hsa-miR-182-5p | Esophageal cancer | MNDR-E-MI-20416 |
| MNDR | hsa-miR-182-5p | Oncocytoma | MNDR-E-MI-20417 |
| MNDR | hsa-miR-182-5p | Lung small cell carcinoma | MNDR-E-MI-20418 |
| MNDR | hsa-miR-182-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-20419 |
| MNDR | hsa-miR-182-5p | Heart failure | MNDR-E-MI-20420 |
| MNDR | hsa-miR-182-5p | Breast invasive carcinoma | MNDR-E-MI-20421 |
| MNDR | hsa-miR-182-5p | Hepatocellular carcinoma | MNDR-E-MI-20422 |
| MNDR | hsa-miR-182-5p | Familiar ovarian carcinoma | MNDR-E-MI-20423 |
| MNDR | hsa-miR-182-5p | B-cell lymphoma | MNDR-E-MI-20424 |
| MNDR | hsa-miR-182-5p | Rheumatoid arthritis | MNDR-E-MI-20425 |
| MNDR | hsa-miR-182-5p | T-cell leukemia | MNDR-E-MI-20426 |
| MNDR | hsa-miR-182-5p | Retinoblastoma | MNDR-E-MI-20427 |
| MNDR | hsa-miR-182-5p | Hodgkin lymphoma | MNDR-E-MI-20428 |
| MNDR | hsa-miR-182-5p | Burkitt lymphoma | MNDR-E-MI-20429 |
| MNDR | hsa-miR-182-5p | Crohn disease | MNDR-E-MI-20430 |
| MNDR | hsa-miR-182-5p | Neuromyelitis optica | MNDR-E-MI-20431 |
| MNDR | hsa-miR-182-5p | Acute myelocytic leukemia | MNDR-E-MI-20432 |
| MNDR | hsa-miR-182-5p | Colorectal cancer | MNDR-E-MI-20433 |
| MNDR | hsa-miR-182-5p | Multiple myeloma | MNDR-E-MI-20434 |
| MNDR | hsa-miR-182-5p | Acute lymphocytic leukemia | MNDR-E-MI-20435 |
| MNDR | hsa-miR-182-5p | Ovarian epithelial cancer | MNDR-E-MI-20436 |
| MNDR | hsa-miR-182-5p | Uterine cervical neoplasms | MNDR-E-MI-20437 |
| MNDR | hsa-miR-182-5p | Ependymoma | MNDR-E-MI-20438 |
| MNDR | hsa-miR-182-5p | Lung | MNDR-E-MI-20439 |
| MNDR | hsa-miR-182-5p | Prostatic neoplasms | MNDR-E-MI-20440 |
| MNDR | hsa-miR-182-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-20441 |
| MNDR | hsa-miR-182-5p | Stroke lacunar | MNDR-E-MI-20442 |
| MNDR | hsa-miR-182-5p | Breast cancer her3+ negative | MNDR-E-MI-20443 |
| MNDR | hsa-miR-182-5p | Duke A | MNDR-E-MI-20444 |
| MNDR | hsa-miR-182-5p | Low grade dysplastic nodule | MNDR-E-MI-20445 |
| MNDR | hsa-miR-182-5p | Non-sonic hedgehog-medulloblastoma | MNDR-E-MI-20446 |
| MNDR | hsa-miR-182-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-20447 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAMTS9-AS2 | Homo sapiens | RR00042742 |
TOP